China's Innovent Biologics signs drug deal with Pfizer worth up to $10.5bn
Summary: China's Innovent Biologics has entered into a strategic licensing...
Source bias
Political lean of the 1 rated outlet covering this story: Center 1.
Sources on this story
Reported by 1 sources, including:
- Nikkei Asia